Moncton, New Brunswick and Cambridge, Massachusetts–
Newsfile Corp. – May 5, 2026
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the addition of Weinstein Imaging Associates in Pittsburgh, Pennsylvania as a new clinical site in its large multi-center observational collection protocol study to advance the development of its breath test for the early detection of breast cancer in women with dense breasts, as an adjunct to mammography.
Weinstein Imaging Associates, with Dr. Danielle Sharek serving as Site Investigator, will collect breath samples from participants at its Pittsburgh facility. Researchers will compare the breath profiles of women with breast cancer and those without breast cancer, with the goal of identifying disease-specific patterns that can be leveraged to facilitate breast cancer detection.